Learn how developments in technology are improving the outcomes of breast cancer.
Jupiter, FL—An upcoming segment of Advancements with Ted Danson will focus on innovations in CT imaging tools and technologies.
In this episode, viewers will learn about the increasing rates of breast cancer, which in recent years has surpassed lung cancer as the most common form. Audiences will learn how developments in CT imaging technology are providing more accurate detection and diagnosis of breast cancers.
Viewers will learn about Izotropic Corporation’s IzoView Breast CT imaging platform, which produces high resolution breast images in true 3D with low radiation dose levels.
“IzoView has the potential to revolutionize breast imaging as we know it,” said Dr. John McGraw, Chief Executive Officer of Izotropic. “We’re preparing for a clinical study initiating this year for market authorization in the USA to bring our breast CT technology to hospitals and clinics across the country. IzoView will offer a whole new experience for patients, providers, radiologists, and other surgical and oncology specialists. We’re very proud of our technology and the impact we intend to have on breast cancer diagnostics to improve the outcomes of breast cancer.”
In addition, the show will discover what makes the platform ideal for imaging patients with dense breast tissue.
“One 10 second scan acquires approximately 500 images. The process is quick and removes the need for painful breast compression or continual technician breast handling, providing a more comfortable patient experience,” said Ed Sullivan, senior producer for the Advancements series. “We look forward to sharing this information with viewers.”
About Izotropic:
Izotropic Corporation is the only publicly traded company commercializing a dedicated breast CT imaging platform, IzoView, for the more accurate detection and diagnosis of breast cancers. To expedite patient and provider access to IzoView, Izotropic’s initial clinical study intends to demonstrate superior performance of diagnostic breast CT imaging over diagnostic mammography procedures. In follow-on clinical studies, Izotropic intends to validate platform applications, including breast screening in radiology, treatment planning and monitoring in surgical oncology, and breast reconstruction and implant monitoring in plastic and reconstructive surgery.
For more information, visit https://izocorp.com/.
About Advancements and DMG Productions:
Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.
Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.
For more information, please visit www.AdvancementsTV.com or call 866-496-4065.
